Digital twins to revolutionize personalized medicine
Medical Futurist - 19-Mar-2020Risk prediction and best therapy for a specific patient is a future possibility
Join the club for FREE to access the whole archive and other member benefits.
Vitals monitoring device, BioIntelliSense
The First FDA-cleared single-use device for up to 30 days of continuous vital signs monitoring
The BioIntelliSense Data-as-a-Service (DaaS) platform and FDA-cleared BioStickerâ„¢ on-body sensor are bringing medical grade monitoring and management to the home for scalable remote care.
Visit website: https://biointellisense.com/
See also: BioIntelliSense - Continuous health monitoring and clinical intelligence company
Details last updated 21-Mar-2020
Risk prediction and best therapy for a specific patient is a future possibility